Founded

Recent investment activity

KANDO id: 114095

Corporate information

Official name
Gilead Sciences Incorporated
Registration country

Company type

A biopharmaceutical company that discovers, develops and commercializes therapeutics.

Funding rounds

N/A


( )

Profile Country Notes
Biotechnology Venture Fund Initial investment.
Venrock Associates The venture capital arm of the Rockefeller Family. Initial investment.

Profile Country
Menlo Ventures Bay Area venture capital firm that invests early stage across consumer, enterprise, and healthcare technologies.

Top investment portfolio themes

Actual initial investment stage
N/A (2)

Investment activity status
Active investor

Selected investments

Displaying 1 - 7 of 7
Profile Country Date Funding
CGI Pharmaceuticals Inc A biopharmaceutical company developing small molecule therapeutics for multiple oncology and immunology-based indications. Acquisition USD 120,000,000 (USD 120,000,000)
Corus Pharma Inc A specialty pharmaceutical development company developing and obtaining regulatory approvals of products for respiratory and infectious diseases. Acquisition USD 365,000,000 (USD 365,000,000)
Triangle Pharmaceuticals Inc Anti-viral and oncology licensing company. Acquisition USD 464,000,000 (USD 464,000,000)
Achillion Pharmaceuticals Inc Biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. N/A Initial investment
Achillion Pharmaceuticals Inc Biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. N/A Initial investment
Arresto BioSciences Inc A biotechnology company, develops medicines to treat cancer and fibrotic diseases Acquisition USD 225,000,000 (USD 225,000,000)
Calistoga Pharmaceuticals Inc Biopharmaceutical company dedicated to developing targeted therapies to improve the health of patients with cancer or inflammatory diseases. Acquisition

Current team

Past employees

Selected Products / Customers

Financials